Bloods concluded publication on 21 September 2020. It has been succeeded by Hemato, which has a revised scope and a new editorial direction and is now published here. To preserve historical data integrity, the information on this webpage is retained but will no longer be updated. The Editorial Board listed here reflects the journal’s composition at the time it ceased publishing.
Editorial Board
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Professor of Pathology, Former Chairman of Department of Pathology, Centro di Riferimento Oncologico (CRO) Aviano, National Cancer Institute, Italy
Interests: Hematopathology; Hodgkin Lymphoma; non Hodgkin Lymphoma; HIV-associated Lymphoma; Virus-associated Lymphoma; Post-transplant Lymphoma; Pathology; Immunohistochemistry; Tumour Microenvironment; Telepathology
Interests: Hematopathology; Hodgkin Lymphoma; non Hodgkin Lymphoma; HIV-associated Lymphoma; Virus-associated Lymphoma; Post-transplant Lymphoma; Pathology; Immunohistochemistry; Tumour Microenvironment; Telepathology
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Interests: acute myeloid leukemia; antibody-based therapy; CD33; clinical trials; minimal residual disease
Interests: acute myeloid leukemia; antibody-based therapy; CD33; clinical trials; minimal residual disease
Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, Université de Paris, Paris, France; Bone Marrow Transplantation department; French reference center for aplastic anemia and PNH
Interests: allogeneic stem cell transplantation; graft-versus-host disease; immune defect and other post-transplant complications; myelodysplastic syndrome; myeloproliferative disorders; aplastic anemia
Interests: allogeneic stem cell transplantation; graft-versus-host disease; immune defect and other post-transplant complications; myelodysplastic syndrome; myeloproliferative disorders; aplastic anemia
Service d'Hématologie, Hôpital Pitié Salpêtrière, 47‐83 boulevard de l'hôpital, F‐75013 Paris, France
Interests: myeloma; AL amyloidosis; monoclonal gammopathy of clinical significance; POEMS; transplantation
Interests: myeloma; AL amyloidosis; monoclonal gammopathy of clinical significance; POEMS; transplantation
Department of Internal Medicine, University Hospital of Strasbourg, 67000 Strasbourg, France
Interests: drug-induced cytopenias; anemia; thrombocytopenia; neutropenia; cobalamin deficiency; vitamin B12 deficiency; telemedicine; chronic diseases; chronic heart failure
Interests: drug-induced cytopenias; anemia; thrombocytopenia; neutropenia; cobalamin deficiency; vitamin B12 deficiency; telemedicine; chronic diseases; chronic heart failure
Hematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1Midland Road, London NW1 1AT, UK
Interests: Human Biology & Physiology; Stem Cells; Tumour Biology; Acute Myeloid Leukaemia
Interests: Human Biology & Physiology; Stem Cells; Tumour Biology; Acute Myeloid Leukaemia
Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
Interests: stem cell transplantation, cellular therapies, CART cells, infectious complications
Interests: stem cell transplantation, cellular therapies, CART cells, infectious complications
Department of Medicine, Section of Internal Medicine, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy
Interests: non-malignant hematological diseases; congenital and acquired disorders of iron metabolism; hyperferritinemia; iron deficiency; hereditary hemochromatosis; secondary iron overload conditions; acquired and congenital anemias; metabolic and hematological rare diseases; lysosomal storage diseases; Gaucher and Fabry's disease.
Interests: non-malignant hematological diseases; congenital and acquired disorders of iron metabolism; hyperferritinemia; iron deficiency; hereditary hemochromatosis; secondary iron overload conditions; acquired and congenital anemias; metabolic and hematological rare diseases; lysosomal storage diseases; Gaucher and Fabry's disease.
Department of Medical and Surgical Sciences, Magna Graecia University Catanzaro, Italy
Interests: acute myocardial infarction; atherothrombosis; cardiac biomarkers; microRNAs; antithrombotic treatment
Interests: acute myocardial infarction; atherothrombosis; cardiac biomarkers; microRNAs; antithrombotic treatment
The University of Queensland Diamantina Institute, Translational Research Institute, 37 Kent Street Woolloongabba, QLD 4102, Australia
Interests: Cancer immunotherapy; Advanced monitoring of immune responses in cancer patients; Pathogenesis and treatment of infection-driven tumors
Interests: Cancer immunotherapy; Advanced monitoring of immune responses in cancer patients; Pathogenesis and treatment of infection-driven tumors
Clinical Pathology, A.A.S.n.5 “Friuli Occidentale”, Pordenone, Italy
Interests: flow cytometry and morphology (cytology) of lymphoproliferative disease, myelodisplastic disease and myeloproliferative neoplasms
Interests: flow cytometry and morphology (cytology) of lymphoproliferative disease, myelodisplastic disease and myeloproliferative neoplasms
Centre for Haemato‐oncology and Genomics and Computational Biology Barts Cancer Institute, QMUL, London, UK
Interests: Follicular Lymphoma, Familial Myeloid Malignancies, Acute Myeloid Leukaemia, Genomics, Epigenetics, Cancer Evolution
Interests: Follicular Lymphoma, Familial Myeloid Malignancies, Acute Myeloid Leukaemia, Genomics, Epigenetics, Cancer Evolution
Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Via G. Venezian 1, I-20133 Milano, Italy
Interests: immunohistochemistry; in situ molecular techniques; brightfield in situ hybridization; virologic characterization; EBV; HHV8/KSHV; HPV; tumor microenvironment; Hodgkin’s lymphoma; HIV-associated lymphomas
Interests: immunohistochemistry; in situ molecular techniques; brightfield in situ hybridization; virologic characterization; EBV; HHV8/KSHV; HPV; tumor microenvironment; Hodgkin’s lymphoma; HIV-associated lymphomas
Centre d'Investigations Cliniques, APHP, Hôpital Saint-Louis, Université de Paris, INSERM CIC 1427, Paris, France
Interests: myelodysplastic syndromes; chronic myeloproliferative neoplasms
Interests: myelodysplastic syndromes; chronic myeloproliferative neoplasms
Department of Hematology, Hospital Clinic de Barcelona, Villarroel 170, 08036 Barcelona, Spain
Interests: lymphoid neoplasms, clinical characteristics, expression and mutation of lymphoma genes, genetic abnormalities, tumor microenvironments, clinical trials, CAR-T cells
Interests: lymphoid neoplasms, clinical characteristics, expression and mutation of lymphoma genes, genetic abnormalities, tumor microenvironments, clinical trials, CAR-T cells
Department of Cellular Pathology, University College London, 21 University Street, London, WC1E 6DE, UK
Interests: microscope-based techniques; immunohistochemistry; immunofluorescence; antibodies; biomarkers; hematological malignancies; solid tumors; immuno-oncopathology; tumor microenvironment; immunotherapy
Interests: microscope-based techniques; immunohistochemistry; immunofluorescence; antibodies; biomarkers; hematological malignancies; solid tumors; immuno-oncopathology; tumor microenvironment; immunotherapy
Institute of Pathology, Catholic University of Sacred Heart, Largo A. Gemelli 8, 00168, Rome, Italy
Interests: Hematopathology; Glial and central nervous system cancer; Gastrointestinal tumor; Lung cancer; Thyroid cancer; Genitourinary cancer
Interests: Hematopathology; Glial and central nervous system cancer; Gastrointestinal tumor; Lung cancer; Thyroid cancer; Genitourinary cancer
Divison of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Interests: allogeneic hematopoietic stem cell transplantation (HSCT); conditioning regimens; GVHD; regimen-related toxicity; MDS and AML; chronic myeloproliferative disorders; opportunistric infections in onco-hematology; supportive care in onco-hematology and HSCT; administrative support in HSCTY, including JACIE
Interests: allogeneic hematopoietic stem cell transplantation (HSCT); conditioning regimens; GVHD; regimen-related toxicity; MDS and AML; chronic myeloproliferative disorders; opportunistric infections in onco-hematology; supportive care in onco-hematology and HSCT; administrative support in HSCTY, including JACIE
1. Senior research, Cancer Research Center/IBMCC, 37007 Salamanca, Spain
2. Hematology Department, University Hospital of Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, Spain
3. Institute for Biomedical Research of Salamanca, Salamanca 37007, Spain
Interests: myeloma; asymptomatic myeloma; minimal residual disease; early treatment; novel drugs
2. Hematology Department, University Hospital of Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, Spain
3. Institute for Biomedical Research of Salamanca, Salamanca 37007, Spain
Interests: myeloma; asymptomatic myeloma; minimal residual disease; early treatment; novel drugs
Department of Hematology, Amsterdam UMC, VU University Medical Center,Cancer Center Amsterdam, Amsterdam, the Netherlands
Interests: Immunology; Functional T Cell Subsets; Immunobiology of Minor Histocompatibility Antigens (mHags); Cellular Immunotherapy of Leukemia after Allo-SCT
Interests: Immunology; Functional T Cell Subsets; Immunobiology of Minor Histocompatibility Antigens (mHags); Cellular Immunotherapy of Leukemia after Allo-SCT
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Interests: autologous and allogeneic stem cell transplantation; graft-versus-host disease and other post-transplant complications; myelodysplastic syndromes; chronic myelomonocytic leukemia and other myelodysplastic/myeloproliferative neoplasms; myeloproliferative neoplesms; cutaneous T-cell lymphomas; autologous transplantation in autoimmune diseases
Interests: autologous and allogeneic stem cell transplantation; graft-versus-host disease and other post-transplant complications; myelodysplastic syndromes; chronic myelomonocytic leukemia and other myelodysplastic/myeloproliferative neoplasms; myeloproliferative neoplesms; cutaneous T-cell lymphomas; autologous transplantation in autoimmune diseases
Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Viale Golgi, 19 – 27100 Pavia, Italy
Interests: amyloidosis; monoclonal gammopathies of clinical significance; biomarkers
Interests: amyloidosis; monoclonal gammopathies of clinical significance; biomarkers
Associated Professor of Internal Medicine, Department of Medicine – DIMED, University of Padua, Via Giustiniani 2, 35128 Padova, Italy
Interests: chronic myeloproliferative disorder, erythrocytosis, thrombocytosis, essential thrombocythemia, polycythemia vera, non-oncologic blood diseases
Interests: chronic myeloproliferative disorder, erythrocytosis, thrombocytosis, essential thrombocythemia, polycythemia vera, non-oncologic blood diseases
AOU Careggi, University of Florence, Florence, Italy
Interests: myelodyspalstic syndromes; acute and chronic myeloid leukemias
Interests: myelodyspalstic syndromes; acute and chronic myeloid leukemias
Department of Hematology, University of Palermo, Vespro 127, I-90127 Palermo, Italy
Interests: thrombosis, bleeding, myeloprolifertaive neoplasm, myeloma
Interests: thrombosis, bleeding, myeloprolifertaive neoplasm, myeloma
Department of Rehabilitation Sciences & Physiotherapy, Antwerp Multidisciplinary Metabolic Research Unit (AM2RUN), University of Antwerp, Antwerp B-2000, Belgium
Interests: Cardiovascular and blood patho-physiology in elite sports, oncology patients and the critically-ill, Blood doping and erythropoietin, hematology in child oncology
Interests: Cardiovascular and blood patho-physiology in elite sports, oncology patients and the critically-ill, Blood doping and erythropoietin, hematology in child oncology
Division of Hematology & Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Auenbruggerplatz 38, 8036 Graz, Austria
Interests: myeloid neoplasias; acute myeloid leukemia; chronic myelomonocytic leukemia; myelodysplastic syndromes; signal transduction; RAS-signaling; MAPK-signaling; miRNAs
Interests: myeloid neoplasias; acute myeloid leukemia; chronic myelomonocytic leukemia; myelodysplastic syndromes; signal transduction; RAS-signaling; MAPK-signaling; miRNAs
